Annual FCF
$864.00 M
-$450.00 M-34.25%
31 December 2023
Summary:
Quest Diagnostics Incorporated annual free cash flow is currently $864.00 million, with the most recent change of -$450.00 million (-34.25%) on 31 December 2023. During the last 3 years, it has fallen by -$966.00 million (-52.79%). DGX annual FCF is now -52.79% below its all-time high of $1.83 billion, reached on 31 December 2021.DGX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$250.00 M
-$18.00 M-6.72%
30 September 2024
Summary:
Quest Diagnostics Incorporated quarterly free cash flow is currently $250.00 million, with the most recent change of -$18.00 million (-6.72%) on 30 September 2024. Over the past year, it has dropped by -$205.00 million (-45.05%). DGX quarterly FCF is now -67.57% below its all-time high of $771.00 million, reached on 30 September 2020.DGX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$1.02 B
+$148.00 M+16.91%
30 September 2024
Summary:
Quest Diagnostics Incorporated TTM free cash flow is currently $1.02 billion, with the most recent change of +$148.00 million (+16.91%) on 30 September 2024. Over the past year, it has increased by +$159.00 million (+18.40%). DGX TTM FCF is now -52.88% below its all-time high of $2.17 billion, reached on 30 June 2021.DGX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DGX Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -45.0% | +18.4% |
3 y3 years | -52.8% | -25.8% | -44.1% |
5 y5 years | +2.5% | +42.0% | +21.4% |
DGX Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -52.8% | at low | -45.0% | +857.6% | -44.1% | +71.6% |
5 y | 5 years | -52.8% | +2.5% | -67.6% | +857.6% | -52.9% | +71.6% |
alltime | all time | -52.8% | +201.5% | -67.6% | +127.4% | -52.9% | +218.7% |
Quest Diagnostics Incorporated Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $250.00 M(-6.7%) | $1.02 B(+16.9%) |
June 2024 | - | $268.00 M(+436.0%) | $875.00 M(-7.6%) |
Mar 2024 | - | $50.00 M(-89.0%) | $947.00 M(+9.6%) |
Dec 2023 | $864.00 M(-34.2%) | $455.00 M(+346.1%) | $864.00 M(+45.0%) |
Sept 2023 | - | $102.00 M(-70.0%) | $596.00 M(-32.1%) |
June 2023 | - | $340.00 M(-1130.3%) | $878.00 M(+1.6%) |
Mar 2023 | - | -$33.00 M(-117.6%) | $864.00 M(-34.2%) |
Dec 2022 | $1.31 B(-28.2%) | $187.00 M(-51.3%) | $1.31 B(-10.2%) |
Sept 2022 | - | $384.00 M(+17.8%) | $1.46 B(-5.7%) |
June 2022 | - | $326.00 M(-21.8%) | $1.55 B(-3.1%) |
Mar 2022 | - | $417.00 M(+23.7%) | $1.60 B(-12.5%) |
Dec 2021 | $1.83 B(+15.3%) | $337.00 M(-28.6%) | $1.83 B(-2.2%) |
Sept 2021 | - | $472.00 M(+25.5%) | $1.87 B(-13.8%) |
June 2021 | - | $376.00 M(-41.7%) | $2.17 B(+5.0%) |
Mar 2021 | - | $645.00 M(+70.2%) | $2.07 B(+30.3%) |
Dec 2020 | $1.59 B(+88.3%) | $379.00 M(-50.8%) | $1.59 B(+14.7%) |
Sept 2020 | - | $771.00 M(+182.4%) | $1.38 B(+69.6%) |
June 2020 | - | $273.00 M(+66.5%) | $816.00 M(+4.7%) |
Mar 2020 | - | $164.00 M(-6.8%) | $779.00 M(-7.6%) |
Dec 2019 | $843.00 M(+3.2%) | $176.00 M(-13.3%) | $843.00 M(+3.9%) |
Sept 2019 | - | $203.00 M(-14.0%) | $811.00 M(-12.7%) |
June 2019 | - | $236.00 M(+3.5%) | $929.00 M(-1.0%) |
Mar 2019 | - | $228.00 M(+58.3%) | $938.00 M(+14.8%) |
Dec 2018 | $817.00 M(-11.5%) | $144.00 M(-55.1%) | $817.00 M(-10.6%) |
Sept 2018 | - | $321.00 M(+31.0%) | $914.00 M(+2.5%) |
June 2018 | - | $245.00 M(+129.0%) | $892.00 M(+1.8%) |
Mar 2018 | - | $107.00 M(-55.6%) | $876.00 M(-5.1%) |
Dec 2017 | $923.00 M(+12.2%) | $241.00 M(-19.4%) | $923.00 M(+2.0%) |
Sept 2017 | - | $299.00 M(+30.6%) | $905.00 M(+7.0%) |
June 2017 | - | $229.00 M(+48.7%) | $846.00 M(-2.9%) |
Mar 2017 | - | $154.00 M(-30.9%) | $871.00 M(+5.8%) |
Dec 2016 | $823.00 M(+47.5%) | $223.00 M(-7.1%) | $823.00 M(+5.8%) |
Sept 2016 | - | $240.00 M(-5.5%) | $778.00 M(+11.5%) |
June 2016 | - | $254.00 M(+139.6%) | $698.00 M(+4.5%) |
Mar 2016 | - | $106.00 M(-40.4%) | $668.00 M(+19.7%) |
Dec 2015 | $558.00 M(-12.3%) | $178.00 M(+11.3%) | $558.00 M(-7.0%) |
Sept 2015 | - | $160.00 M(-28.6%) | $600.00 M(-1.5%) |
June 2015 | - | $224.00 M(-5700.0%) | $609.00 M(-1.1%) |
Mar 2015 | - | -$4.00 M(-101.8%) | $616.00 M(-3.1%) |
Dec 2014 | $636.00 M(+51.1%) | $220.00 M(+30.2%) | $636.00 M(+15.6%) |
Sept 2014 | - | $169.00 M(-26.8%) | $550.00 M(+6.2%) |
June 2014 | - | $231.00 M(+1343.8%) | $518.00 M(+18.0%) |
Mar 2014 | - | $16.00 M(-88.1%) | $439.00 M(+4.3%) |
Dec 2013 | $421.00 M(-58.1%) | $134.00 M(-2.2%) | $421.00 M(-30.7%) |
Sept 2013 | - | $137.00 M(-9.9%) | $607.56 M(-25.9%) |
June 2013 | - | $152.00 M(-7700.0%) | $820.27 M(-5.9%) |
Mar 2013 | - | -$2.00 M(-100.6%) | $871.73 M(-13.3%) |
Dec 2012 | $1.00 B(+36.9%) | $320.56 M(-8.3%) | $1.00 B(+2.7%) |
Sept 2012 | - | $349.71 M(+71.9%) | $978.59 M(+5.5%) |
June 2012 | - | $203.46 M(+55.0%) | $927.27 M(+24.7%) |
Mar 2012 | - | $131.27 M(-55.4%) | $743.68 M(+1.3%) |
Dec 2011 | $734.00 M(-19.6%) | $294.15 M(-1.4%) | $734.00 M(+3.3%) |
Sept 2011 | - | $298.39 M(+1401.7%) | $710.33 M(+2.3%) |
June 2011 | - | $19.87 M(-83.7%) | $694.57 M(-16.8%) |
Mar 2011 | - | $121.59 M(-55.0%) | $834.78 M(-8.5%) |
Dec 2010 | $912.65 M | $270.48 M(-4.3%) | $912.65 M(-4.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2010 | - | $282.63 M(+76.6%) | $952.59 M(-5.0%) |
June 2010 | - | $160.08 M(-19.7%) | $1.00 B(+25.8%) |
Mar 2010 | - | $199.45 M(-35.7%) | $796.79 M(-4.1%) |
Dec 2009 | $830.49 M(-2.3%) | $310.42 M(-6.6%) | $830.49 M(+2.5%) |
Sept 2009 | - | $332.51 M(-829.3%) | $810.47 M(+6.4%) |
June 2009 | - | -$45.59 M(-119.6%) | $761.54 M(-21.7%) |
Mar 2009 | - | $233.15 M(-19.7%) | $972.54 M(+14.4%) |
Dec 2008 | $850.37 M(+20.1%) | $290.40 M(+2.4%) | $850.37 M(+1.3%) |
Sept 2008 | - | $283.58 M(+71.4%) | $839.17 M(+5.8%) |
June 2008 | - | $165.41 M(+49.0%) | $793.20 M(+12.1%) |
Mar 2008 | - | $110.98 M(-60.2%) | $707.38 M(-0.1%) |
Dec 2007 | $707.82 M(-6.7%) | $279.20 M(+17.5%) | $707.82 M(+4.9%) |
Sept 2007 | - | $237.61 M(+198.6%) | $674.81 M(+7.7%) |
June 2007 | - | $79.59 M(-28.6%) | $626.52 M(-6.7%) |
Mar 2007 | - | $111.43 M(-54.7%) | $671.43 M(-11.5%) |
Dec 2006 | $758.47 M(+20.9%) | $246.19 M(+30.0%) | $758.47 M(-1.5%) |
Sept 2006 | - | $189.32 M(+52.1%) | $769.76 M(+9.4%) |
June 2006 | - | $124.49 M(-37.3%) | $703.64 M(-5.6%) |
Mar 2006 | - | $198.47 M(-22.9%) | $745.14 M(+18.8%) |
Dec 2005 | $627.31 M(+0.7%) | $257.47 M(+109.0%) | $627.31 M(+6.1%) |
Sept 2005 | - | $123.20 M(-25.8%) | $591.44 M(-7.9%) |
June 2005 | - | $165.99 M(+105.8%) | $642.02 M(+0.7%) |
Mar 2005 | - | $80.65 M(-63.6%) | $637.75 M(+2.4%) |
Dec 2004 | $622.65 M(+27.6%) | $221.59 M(+27.5%) | $622.65 M(+2.0%) |
Sept 2004 | - | $173.78 M(+7.5%) | $610.40 M(+8.3%) |
June 2004 | - | $161.72 M(+146.7%) | $563.56 M(+5.8%) |
Mar 2004 | - | $65.55 M(-68.7%) | $532.89 M(+9.2%) |
Dec 2003 | $488.16 M(+10.6%) | $209.34 M(+64.9%) | $488.16 M(-0.1%) |
Sept 2003 | - | $126.95 M(-3.1%) | $488.47 M(+6.5%) |
June 2003 | - | $131.05 M(+529.5%) | $458.49 M(+1.8%) |
Mar 2003 | - | $20.82 M(-90.1%) | $450.41 M(+2.1%) |
Dec 2002 | $441.18 M(+39.3%) | $209.65 M(+116.2%) | $441.18 M(+23.5%) |
Sept 2002 | - | $96.97 M(-21.1%) | $357.24 M(-5.5%) |
June 2002 | - | $122.97 M(+961.2%) | $378.17 M(+14.2%) |
Mar 2002 | - | $11.59 M(-90.8%) | $331.29 M(+4.6%) |
Dec 2001 | $316.82 M(+25.2%) | $125.72 M(+6.6%) | $316.82 M(+19.3%) |
Sept 2001 | - | $117.89 M(+54.9%) | $265.61 M(+17.0%) |
June 2001 | - | $76.09 M(-2738.2%) | $226.93 M(-3.3%) |
Mar 2001 | - | -$2.88 M(-103.9%) | $234.58 M(-7.3%) |
Dec 2000 | $253.00 M(-129.7%) | $74.51 M(-5.9%) | $253.00 M(+18.8%) |
Sept 2000 | - | $79.22 M(-5.4%) | $212.99 M(-127.3%) |
June 2000 | - | $83.73 M(+438.7%) | -$778.92 M(-8.0%) |
Mar 2000 | - | $15.54 M(-54.9%) | -$846.85 M(-0.5%) |
Dec 1999 | -$851.50 M(-943.9%) | $34.50 M(-103.8%) | -$851.50 M(-1.2%) |
Sept 1999 | - | -$912.70 M(-5873.7%) | -$861.60 M(-913.6%) |
June 1999 | - | $15.81 M(+45.1%) | $105.90 M(+13.6%) |
Mar 1999 | - | $10.89 M(-55.4%) | $93.19 M(-7.6%) |
Dec 1998 | $100.90 M(-22.1%) | $24.40 M(-55.5%) | $100.90 M(+12.5%) |
Sept 1998 | - | $54.80 M(+1667.7%) | $89.70 M(+7.2%) |
June 1998 | - | $3.10 M(-83.3%) | $83.70 M(-19.5%) |
Mar 1998 | - | $18.60 M(+40.9%) | $104.00 M(-19.7%) |
Dec 1997 | $129.50 M(-181.5%) | $13.20 M(-73.0%) | $129.50 M(+11.3%) |
Sept 1997 | - | $48.80 M(+108.5%) | $116.30 M(+72.3%) |
June 1997 | - | $23.40 M(-46.9%) | $67.50 M(+53.1%) |
Mar 1997 | - | $44.10 M | $44.10 M |
Dec 1996 | -$158.88 M | - | - |
FAQ
- What is Quest Diagnostics Incorporated annual free cash flow?
- What is the all time high annual FCF for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly free cash flow?
- What is the all time high quarterly FCF for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated quarterly FCF year-on-year change?
- What is Quest Diagnostics Incorporated TTM free cash flow?
- What is the all time high TTM FCF for Quest Diagnostics Incorporated?
- What is Quest Diagnostics Incorporated TTM FCF year-on-year change?
What is Quest Diagnostics Incorporated annual free cash flow?
The current annual FCF of DGX is $864.00 M
What is the all time high annual FCF for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high annual free cash flow is $1.83 B
What is Quest Diagnostics Incorporated quarterly free cash flow?
The current quarterly FCF of DGX is $250.00 M
What is the all time high quarterly FCF for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high quarterly free cash flow is $771.00 M
What is Quest Diagnostics Incorporated quarterly FCF year-on-year change?
Over the past year, DGX quarterly free cash flow has changed by -$205.00 M (-45.05%)
What is Quest Diagnostics Incorporated TTM free cash flow?
The current TTM FCF of DGX is $1.02 B
What is the all time high TTM FCF for Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated all-time high TTM free cash flow is $2.17 B
What is Quest Diagnostics Incorporated TTM FCF year-on-year change?
Over the past year, DGX TTM free cash flow has changed by +$159.00 M (+18.40%)